Anti-Allergy + Anti-Inflammatory — a detailed guide to composition, benefits, and use.
Triple-action combination of Olopatadine, Ketorolac, and Trehalose for comprehensive management of allergic ocular inflammation with surface protection.
Olosight-KT Eye Drops feature a unique triple-component formulation combining Olopatadine 0.1% (a second-generation H1-antihistamine), Ketorolac 0.4% (a non-steroidal anti-inflammatory agent), and Trehalose (a natural disaccharide with cell-protective properties). This triple-action approach simultaneously blocks histamine-mediated allergic responses, inhibits prostaglandin-driven inflammation, and provides osmotic protection to the ocular surface. The inclusion of Trehalose stabilizes cell membranes against dehydration stress, offering an additional layer of comfort for patients with allergic conjunctivitis complicated by ocular surface damage.
| Composition | Olopatadine 0.1% + Ketorolac 0.4% fortified with Trehalose |
| Volume | 5 mL per bottle |
| pH Range | 6.5 - 7.4 |
| Storage | Store at room temperature (15-30°C). Protect from light. |
| Shelf Life | 24 months from date of manufacture |
| Packaging | 5 mL sterile ophthalmic solution bottle |
| Dosage | 1 drop in each affected eye twice daily, or as directed by physician |
Explore the complete product page for packaging, dosing, and enquiry options.
View Olosight-KT Eye Drops Enquire NowDiscover more insights on eye health and ophthalmic care.